Takeda To Sell Japanese Consumer Health Unit To Blackstone For $2.3 billion
Takeda Pharmaceutical Co (4502.T) has agreed to sell its Japanese consumer healthcare business to U.S. investment fund Blackstone Group (BX.N) for 242 billion yen ($2.3 billion), Japan’s largest drugmaker said on Monday.
The sale of…